Di
Wu
a,
Adam C.
Sedgwick
b,
Thorfinnur
Gunnlaugsson
*c,
Engin U.
Akkaya
*d,
Juyoung
Yoon
*a and
Tony D.
James
*b
aDepartment of Chemistry and Nano Science, Ewha Womans University, Seoul 120-750, Korea. E-mail: jyoon@ewha.ac.kr
bDepartment of Chemistry, University of Bath, Bath, BA2 7AY, UK. E-mail: t.d.james@bath.ac.uk
cSchool of Chemistry and Trinity Biomedical Sciences Institute (TBSI), Trinity College Dublin, The University of Dublin, Dublin 2, Ireland. E-mail: gunnlaut@tcd.ie
dUNAM-Institute of Material Science and Nanotechnology, Bilkent University, Ankara 06800, Turkey. E-mail: eua@fen.bilkent.edu.tr
First published on 11th October 2017
Fluorescent chemosensors for ions and neutral analytes have been widely applied in many diverse fields such as biology, physiology, pharmacology, and environmental sciences. The field of fluorescent chemosensors has been in existence for about 150 years. In this time, a large range of fluorescent chemosensors have been established for the detection of biologically and/or environmentally important species. Despite the progress made in this field, several problems and challenges still exist. This tutorial review introduces the history and provides a general overview of the development in the research of fluorescent sensors, often referred to as chemosensors. This will be achieved by highlighting some pioneering and representative works from about 40 groups in the world that have made substantial contributions to this field. The basic principles involved in the design of chemosensors for specific analytes, problems and challenges in the field as well as possible future research directions are covered. The application of chemosensors in various established and emerging biotechnologies, is very bright.
Key learning points(1) Strategies for the design of fluorescent chemosensors(2) Sensing mechanisms involved in the design of fluorescent chemosensors (3) Applications of fluorescent chemosensors (4) Usefulness of fluorescent chemosensors for in vitro and in vivo studies (5) Key problems and challenges in the field of fluorescent chemosensors |
There are a number of reviews that have been compiled describing fluorescent chemosensors, however, to the best of our knowledge, most of these reviews focus on either diverse fluorochromes or analytes. Only a few reviews have taken a step back and carried out an overview of progress of this field.6,7 This review summarizes progress in the development of fluorescent chemosensors over the last 50 years and introduces representative chemosensors for the detection of cations, anions, small neutral molecules as well as biomacromolecules. It contains the design principle, working mechanism and biological application of the corresponding chemosensors. Furthermore, the design principles for the construction of selective chemosensors for specific analytes and the problems and challenges encountered along the way will be discussed. We will end the review with a discussion of the future research directions and opportunities available for fluorescent chemosensors given that they are now well-established research tools.
Potassium ions (K+) are one of the most important cations in living organisms because they play essential roles in many biological processes. In mammals, the concentration of K+ inside cells is about 150 mM, which is nearly 30 times higher than that in the extracellular environment. Imbalances of potassium are closely related to many diseases such as Alzheimer's disease (AD), anorexia, heart disease and diabetes. A number of fluorescent chemosensors for K+ have been developed. Currently, the 2-triazacryptand [2,2,3]-1-(2-methoxyethoxy)benzene (TAC) group, which displays a very high selectivity for detecting K+ over other physiologically relevant metal ions is the best K+-selective chelator. The TAC group was first reported by He et al. in 2003.9 They incorporated the TAC group into a 4-aminonaphthalimide based polymer via an ethylene group, in order to develop chemosensor 3 for the measurement of extracellular (serum or whole blood) potassium based on a PET mechanism (Fig. 1). The chemosensor rapidly and reversibly detects changes in potassium concentrations in whole blood samples. Furthermore, there were no interferences from clinical concentrations of Ca2+ or pH and from the interference of Na+ even at concentrations of 160 mM. Additionally, this chemosensor has been used in the Roche OPTI CCA, a commercially available whole blood analyzer, this system was developed in collaboration with de Silva (http://impact.ref.ac.uk/CaseStudies/CaseStudy.aspx?Id=38360). Although TAC based chemosensors display high selectivities and sensitivities for K+, their syntheses often require lengthy synthetic routes and harsh reaction conditions. Thus a significant demand exists for the development of more readily available ligands with the same properties displayed by TAC.
The magnesium ion (Mg2+), which has a number of critical roles such as an enzyme cofactor, a DNA conformation stabilizer and a facilitator of transmembrane ion transport, is the most abundant divalent cation in cells. Abnormal concentrations of Mg2+ ions are associated with many diseases such as migraines, diabetes, hypertension and Parkinson's disease. In order to detect cellular magnesium ions, Farruggia et al. developed two 8-hydroxyquinoline based fluorescent chemosensors 4 and 5 for the detection of Mg2+ (Fig. 2).10 Initially, these two chemosensors show very weak fluorescence due to the an intermolecular photoinduced proton transfer (PPT) and PET process. However, after binding with Mg2+, the PPT and PET process are blocked, which results in a remarkable increase in the fluorescence intensity. Chemosensors 4 and 5, with Kd of 44 and 73 μM, respectively, show high selectivity and sensitivity towards Mg2+ over other cations including Ca2+. These two chemosensors have been used to image Mg2+ in live cells. However, the limitations of these two chemosensors are that they can only be excited in the UV region, which hinders their development for practical applications.
Calcium ions (Ca2+), are another important alkaline earth metal ion. Ca2+ is the most abundant element in the human body and it plays important roles in many biological processes. The monitoring of the intracellular free Ca2+ is important since imbalances of Ca2+ are related to a number of diseases such as neurodegeneration, heart disease and skeletal muscle defects. The initially reported fluorescent chemosensors for Ca2+ suffered several problems such as (1) low selectivity towards competing cations and in particularly H+ and Mg2+, (2) complex stoichiometry with Ca2+, (3) inflexibility of molecular design, or the difficulty of rationally and iteratively adjusting chelator properties with different fluorophores.11 These problems were only solved when Nobel Laureate Roger Y. Tsien developed two 1,2-bis(2-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid (BAPTA) based fluorescent chemosensors 6 and 7 for Ca2+ in 1980 (Fig. 2).11 Both of these chemosensors show good selectivity and sensitivity towards Ca2+ over Mg2+, and their application in vivo opened up a new area and understanding of cellular function and indeed revolutionized our understanding of biochemical processes within cells.
Along with the development of the field of fluorescence dyes and the advancement in microscopic imaging technologies, a series of BAPTA and derived fluorescent chemosensors for Ca2+ have been reported. In 2010, Kim, Cho and coworkers described a two photon (TP) fluorescent chemosensor 8, in which 2-(2′-morpholino-2′-oxoethoxy)-N,N-bis(hydroxycarbonylmethyl) aniline (MOBHA) was used as the Ca2+ receptor and 6-(benzo[d]oxazol-2′-yl)-2-(N,N-dimethylamino)naphthalene was used as the fluorophore (Fig. 2).12 Chemosensor 8 shows high selectivity for Ca2+ and was pH-insensitive at biologically relevant pH. To understand the Na+/Ca2+ exchange process, which is an important process vital to Ca2+ homeostasis, the Ca2+ chemosensor 8 and Na+ chemosensor 9 were applied to the simultaneously detection of Ca2+ and Na+ near the cell membrane of HeLa cells (Fig. 3). The HeLa cells labeled with 8 and 9 emitted bright two-photon excited fluorescence (TPEF) in the green channel emission (390–450 nm), corresponding to Ca2+ ions detected by 8 (Fig. 3a) and red channel emission (500–560 nm), attributed to Na+ ions detected by 9 (Fig. 3b), the merged images generated by two-photon excitation are given in Fig. 3c. These two chemosensors have been applied to monitoring Na+/Ca2+ exchange in live tissues at depths of over 100 μm (Fig. 3d–f).
Fig. 3 Dual-channel TPEF images of HeLa cells co-incubated with 8 and 9 collected at (a) green channel: 390–450 nm (8), (b) red channel: 500–560 nm (9), and (c) merged image of (a) and (b). TPEF images of a mice hippocampal slice co-stained with 8 and 9 collected at (d) green channel: 390–450 nm (8), (e) red channel: 500–560 nm (9) at a depth of 100–200 μm at tenfold magnification and (f) a merged image of (d) and (e). Excitation wavelength: 780 nm. Scale bars: 30 mm (a and d). Reproduced from ref. 12 with the permission of John Wiley & Sons, Inc. |
The proton (H+) (or hydronium ion (H3O+)) is one of the most important charged species and has a crucial role in many physiological and pathological processes including receptor-mediated signal transduction, ion transport, endocytosis, homeostasis, proliferation and apoptosis, multidrug resistance and muscle contraction. Mitochondria, an important organelle, has a critical role in cellular metabolism such as energy production, signaling, cellular differentiation, cell growth and death. The unique function of the mitochondria depends on the pH. Therefore, monitoring mitochondrial pH and in particular, changes related to mitophagy, may provide insights into mitochondrial function under physiological and pathological conditions. Sessler, Kang, Kim and coworkers developed a mitochondria-immobilized fluorescent chemosensor 10 to measure pH (Fig. 4), consisting of a piperazine-linked naphthalimide as a fluorophore with a cationic triphenylphosphonium as the mitochondrial targeting group, and a reactive benzyl chloride subunit for mitochondrial fixation.13 The chemosensor is non-fluorescent in neutral form due to the PET process. However, the PET process is inhibited at acidic pH and results in a fluorescence enhancement. 10 can be used for quantitative measurement of pH in mitochondria and real-time monitoring of mitophagy in cells. These results indicate that 10 has significant potential to be applied in biological systems, and how simple structural modifications of an established PET pH-sensor can open up new routes towards emerging biotechnologies.
Fig. 4 Structures of the fluorescent chemosensors 10 and the proposed mechanism for detection of pH in mitochondria. |
Copper (Cu) is the third most abundant transition metal in the human body, it is an essential transition metal in living organisms because it is involved in various physiological and pathological processes. Loss of copper homeostasis is linked with diseases such as Menkes (copper deficiency), Wilson's (copper overload), Alzheimer's disease, prion disorders, neurodegeneration and cancer.
In 1997, Czarnik and co-workers reported pioneering work on a rhodamine-B derivative and its ring-opening reaction for sensing copper ion (Cu2+).14 As shown in Fig. 5, the fluorescent chemosensor 11 can undergo a selective hydrolysis reaction with Cu2+ and yield fluorescent rhodamine B as a product. This work generated a great deal of attention for the ring-opening processes of rhodamine derivatives for use as a fluorescent chemosensors.
Based on the same reaction, the Li group developed a NIR fluorescent chemosensor 12 for Cu2+ (Fig. 5).15 Undoubtedly, 12 shows high sensitivity and selectivity to Cu2+ over other related metal ions. It is particularly noteworthy that this chemosensor exhibits unique single-photon frequency upconversion luminescence (FUCL). Thus the product formed by the reaction of 12 with Cu2+ can be excited with both 670 nm and 808 nm light. Due to the low background signal associated with NIR excitation (808 nm) and NIR emission (730 nm), it has an extremely low detection limit of 3.2 ppb in aqueous solution. This is much lower than that of the Stokes’ fluorescence methods for excitation at 670 nm where the calculated detection limit is around 6.5 ppb. Significantly, this chemosensor has been applied for the diagnosis of Wilson disease in live mice and therefore offers some promise for diagnostic sensing.
Under physiological conditions, copper exists in its stable oxidized Cu2+ and reduced Cu+ states. Detection of Cu+ is just as important as the detection of Cu2+, however, many fewer fluorescent chemosensors have been developed for Cu+ than for Cu2+. The fluorescent chemosensor 13 developed by the Chang group consists of a tris[(2-pyridyl)-methyl]amine (TPA) as the binding and reaction site, and a bioluminescent D-luciferin as the reporter (Fig. 6).16 Compared with common fluorophore based chemosensors, these bioluminescent reporter based sensing platforms have low background and high signal-to-noise. Chemosensor 13 shows good sensitivity and selectivity towards Cu+ over other related species except for free Co2+ (100 μM) that gives a modest response with the chemosensor. However, the concentration of Co2+ (100 μM) is not considered physiologically relevant since most Co2+ is found tightly bound to proteins. Significantly, 13 has been used to image labile copper pools mouse model of non-alcoholic fatty liver disease. The results indicate that hepatic copper deficiency and altered expression levels of copper homeostatic proteins accompany glucose intolerance and weight gain.
Zinc (Zn) is the second most abundant d-block metal in the human body, which is often found as pools of mobile ions in specific tissues of the body. Failure in the homeostasis of free zinc ions is closely associated with neurological diseases and free zinc ions (Zn2+) are also involved in apoptosis (programmed cell death). The majority of small-molecule fluorescent chemosensors for mobile zinc ions comprise of a fluorophore and a chelating unit containing tertiary amines. However, acidic pH can interfere with the detection of Zn2+ using these systems. To overcome these shortcomings, the Lippard group have developed a spirobenzopyran based two-photon fluorescent chemosensor 14 for Zn2+ (Fig. 7).17 Chemosensor 14 can selectively detect Zn2+ in the presence of other related metal ions over a wide range of pH from 3 to 7. The chemosensor has been applied to imaging exogenous Zn2+ in the lysosomes of HeLa cells, endogenous Zn2+ in insulin granules of MIN6 cells, and zinc-rich mossy fiber boutons in hippocampal tissue of mice. Furthermore, the relatively large two-photon absorption cross section (δ = 74 GM) and far-red emission makes it ideal for imaging zinc ions in tissue at depths of >100 μm with greater contrast than existing visible-light fluorescent chemosensors.
Mercury (Hg) is one of the most prevalent deadly toxins on earth, which arises from many sources such as gold production, coal plants, thermometers, barometers and mercury lamps. In the past several decades, a huge number of fluorescent chemosensors have been developed for the detection of Hg2+. Pioneering work by Czarnik and coworkers on a desulfurisation reaction used the thiophilic character of Hg2+.18 Initially, the fluorescent chemosensor 15 is non-fluorescent due to the PET process. The addition of Hg2+ induces an enhancement in fluorescence, whereas other metal ions except for Ag+ caused no interference (Fig. 8).
Tae, Shin and coworkers developed a rhodamine-based fluorescent chemosensor 16 for Hg2+, which takes advantage of the known Hg2+-promoted formation of 1,3,4-oxadiazoles from thiosemicarbazoles (Fig. 8).19 Chemosensor 16 shows high sensitivity and selectivity over other metal ions including Ag+ and Pb2+, which can also promote the desulfurization reactions. The chemosensor has been used to detect exogenous Hg2+ uptake in C2C12 cells and in zebrafish in real time as well as to image accumulated Hg2+ in zebra fish organs.
Due to the close relationship between the two fields of “chemosensors” and “molecular logic”, a number of fluorescent chemosensors with two or more binding (reaction) sites have been utilized to construct molecular logic gate. For example, Akkaya and coworkers reported three styryl-Bodipy based molecular logic gates 17, 18 and 19 using Hg2+, Zn2+ and (or) Ca2+ as inputs (Fig. 9).20 With these chemosensors, the dithiaazacrown ligand is used as a Hg2+ binding site, di-2-picolylamine (DPA) is used as a Zn2+ binding site while the aza-crown ligand is used as a Ca2+ binding site in 19. Using Hg2+ and Zn2+ as inputs, the emission signaling of 17 at 570 nm responds in accordance with molecular logic gate AND function. For 18, the structure works as an AND logic gate when the absorbance is recorded at 623 nm. However, when the absorbance data is collected near the longer wavelength peak, it responds in accordance with XOR logic. Chemosensor 19 is a three-input AND logic gate using Hg2+, Zn2+ and Ca2+ as inputs when the emission signaling is recorded at 656 nm.
The use of a Zn2+ complex as a binding site for PPi has been found to be a particularly successful strategy due to the strong binding affinity between Zn2+ and PPi. In particular, the Hong group have extensively explored this area of chemosensor development. A representative piece of their work, contains a naphthalene derivative based Zn2+ complex 21 as shown in Fig. 10.22 The Ka for PPi of 21 was calculated to be to be 2.9 × 108 M−1, which means that 21 can detect PPi in water at nanomolar concentrations. Furthermore, 21 is able to detect less than 1 equivalent of PPi in the presence of a 50- to 250-fold excess of ATP. This is the first example of a metal complex that can discriminate PPi from ATP in aqueous solution.
Taking advantage of minimal photo-damage, deep tissue penetration and high signal-to-noise contrast of NIR fluorescent chemosensors, Smith and coworkers developed a cyanine based Zn2+ complex 22 for in vivo optical imaging of tumors and cell death events (Fig. 10).23 Zinc complex 22 can selectively accumulate in prostate and mammary tumors in two different xenograft animal models and it is now commercially available. This is an excellent example of a fluorescent chemosensor being applied for real-life practical applications.
Recently, Sessler, Anslyn, and coworkers reported two anion induced supramolecular assemblies of expanded porphyrins 23 and 24 (Fig. 11).24 Porphyrins 23 and 24 can form supramolecular polymers with several diacids, which can be used as chemosensors for both anions and organic solvents. The solubility, colour, and fluorescence of the assemblies changes dramatically when they were treated with Lewis basic anions or polar solvents, which could be caused by a decrease in the extent of aggregation. The authors have demonstrated that this system can be used as a chemosensor for identifying certain salts and various solvents by solubility, fluorescence or visible colour change.
Fig. 11 Structures of fluorescent chemosensors 23, 24 and the schematic illustrates the construction of supramolecular assemblies using 23, 24, and diacids as the building blocks. |
A urea and thiourea moiety can be used in the design of various fluorescent chemosensors for H-bond donors. An excellent example from the Fabbrizzi and Amendola group is the fluorescent chemosensor 25, which consists of a pyrene group as a fluorophore and a urea binding group. Chemosensor 25 displays an interesting “on1–off–on2” fluorescence response towards F− (Fig. 12).25 Initially, 25 shows typical pyrene emission and maximum at 394 nm (on1) in MeCN. However, upon addition of F−, the fluorescence decreases (off) due to an electron transfer process occurring in the locally excited complex and the conversion of locally excited complex to poorly emissive excited tautomer. Interestingly, upon further addition of F−, a yellow fluorescence turns on, while a new emission band centered at 500 nm (on2) appears, which can be ascribed to a charge-transfer emission by the deprotonated receptor; the F− deprotonation phenomena having been observed by several researchers in analogous systems. The authors demonstrated these optical features can be observed in other neutral receptors containing N–H fragments, this may provide new strategies for the design of fluorescent sensors for anions.
Fig. 12 Structures of 25, 26a–f and the emission spectra taken upon addition of F− to 25 (0.01 mM) in MeCN. Reproduced from ref. 25 with the permission of the American Chemical Society. |
Recently, Gale and coworkers designed and synthesized a series of fluorescent anion transporters 26a–f consisting of a naphthalimide fluorophore with urea or thiourea receptors attached (Fig. 12).26 Interestingly, these transporters show two distinct localization modes within cells. The aromatic substituted transporters localize within the cytoplasm and the less lipophilic alkyl substituted transporters are over time localized in specific vesicles. Furthermore, the aromatic substituted compounds 26c–f all induce cytotoxicity in cancer cell lines, with 26f inducing apoptosis of A549 cells while alkyl substituted 26a and 26b are non-toxic towards cancer cells. These results suggest that the toxic effects can be ascribed to changes in ionic or pH gradients across intracellular membranes rather than the plasma membrane. This research is particularly important since it offers exciting new applications for fluorescent chemosensors of anions.
Hypochlorite (ClO−) is a prominent ROS, which plays an important role in regulating invading microbes. However, uncontrolled production of ClO− within phagocytes is acknowledged to be related to the start of a number of human diseases. Yoon, Kim and coworkers described a two photon fluorescent chemosensor 28 based on imidazoline-2-thiones (Fig. 13).28 Initially, 28 is non-fluorescent in PBS buffer. However, upon addition of ClO−, the fluorescence increases dramatically at 505 nm due to the formation of the corresponding imidazolium. Other ROS/RNS, do not induce observable fluorescence changes, demonstrating outstanding selectivity of the chemosensor towards ClO−. Chemosensor 28 also shows good sensitivity with a detection limit of 0.071 μM towards ClO− and has been applied to imaging ClO− in live cells and tissues.
Peroxynitrite (ONOO−) is a strong oxidant observed in physiological and pathological processes. It plays a key role in signal transduction and antimicrobial activity, however, excessive ONOO− can damage critical cell components resulting in many diseases. Recently, a boronate-based fluorescent chemosensor 29 has been developed for ONOO− (Fig. 14).29 The chemosensor displays relatively weak fluorescence due to the PET process. A large fluorescence enhancement occurs upon the addition of D-fructose. The interaction of the chemosensor with D-fructose strengthens the fluorescence signal and in addition protects the boronic acid from oxidation by other ROS/RNS. The system has good selectivity towards ONOO− over other ROS/RNS except ClO− due to its strong oxidizing ability. Additionally, the chemosensor has been used to image endogenous or exogenous ONOO− in living cells.
Recently, the Qian group reported a FRET-based mitochondria-specific fluorescent chemosensor 30 for the ratiometric detection of ONOO− (Fig. 14).30 The chemosensor consists of two cyanine dyes (Cy3 and Cy5) and harnesses the differential reactivity of Cy3 and Cy5 toward ONOO−. The chemosensor displays fluorescence for Cy5 (660 nm) by FRET from Cy3 when excited at 530 nm. However, upon addition of ONOO−, a fluorescence increase at 560 nm and a decrease at 660 nm is observed which can be ascribed to the selectively oxidation of the Cy5 moiety in 30 by ONOO−. It is worth noting that both Cy3 and Cy5 moieties can be oxidized by ClO−. The chemosensor has been applied to imaging both ONOO− in live cells and the authors demonstrated that this fluorescent chemosensor can be used in semi-quantification of cellular ONOO−.
Nicotinamide adenine dinucleotide (NADH) consists of one adenine, one nicotinamide, two ribose rings, and a pair of bridging phosphate groups. Together with its oxidized form, NAD+, they are the most indispensable coenzymes and they play important roles in multiple biological processes. Inspired by the enzyme-catalyzed NADH sensing process, the group of Chang have developed two resazurin based fluorescent chemosensors 31 and 32 for NADH (Fig. 15).31 A two-step sensing mechanism was proposed as shown in Fig. 15, first, the boronic acid in 31 undergoes an esterification reaction with the diols of NADH. Second, reduction of the weakly fluorescent resazurin to the strongly fluorescent resorufin occurs. It is worth noting that the first step can facilitate the hydride transfer from NADH to 31 and accelerate the reaction in the second step. However, 31 can only work in basic conditions, which limits its applications in biological systems. To address this problem, the boronic acid in 31 was replaced by 2-(hydroxymethyl)phenylboronic acid, yielding the chemosensor 32 which can work in pH 7.4 buffer solution (Fig. 15).31 It can evaluate NADH both in vitro and in live cells. Although this chemosensor still has some drawbacks such as photoinstability and ease of wash-out, this work provides inspiration by mimicking biological processes for the design of fluorescent chemosensors.
The Guo group reported a pyronin B based fluorescent chemosensor 34 for the discrimination of Cys/Hcy and GSH using different emission channels (Fig. 16).33 Initially, free 34 is non-fluorescent due to the PET process from the methoxythiophenol group to the pyronin moiety. Upon treatment of 34 with GSH, a fluorescence enhancement at 622 nm occurs due to the replacement of 4-methoxythiophenol moiety by the thiol group of GSH. In the case of Cys/Hcy, an intramolecular rearrangement occurs followed by a substitution reaction, which leads to fluorescence enhancement at 546 nm. The chemosensor has been applied to imaging Cys/Hcy and GSH in live cells. Importantly, the use of the intramolecular rearrangement of Cys/Hcy with chemosensors is a typical strategy for the design of fluorescent chemosensors to discriminate Cys/Hcy and GSH.
More recently, Urano and co-workers reported two reversible fluorescent chemosensors 35a and 35b for GSH (Fig. 17).34 These two chemosensors show ratiometric fluorescence response to GSH due to the FRET process. The Si-rhodamines were selected as reaction sites because they achieve an intermolecular equilibrium with GSH. As a donor fluorophore, the O-rhodamine was selected owing to its excellent spectral overlap with the Si-rhodamines. Upon addition of GSH, the emission of the Si-rhodamines decreases while the emission of the O-rhodamine increases. The fluorescence ratio of the O-rhodamine and Si-rhodamine units resulted in Kd values of 0.6 and 3.0 mM, respectively for 35a and 35b. Chemosensor 35b has been used to image and quantify GSH in live cells. The authors have shown that these fluorescent chemosensors are revolutionary tools for investigating how GSH dynamics are regulated in a physiological context.
Hydrogen sulfide (H2S) is the smallest member of the reactive sulfur species (RSS). It has been characterized as a crucial gaseous transmitter. However, a variety of emerging data suggest that hydrogen polysulfide (H2Sn) might be the signaling molecules instead of H2S. Given the importance of H2S and H2Sn in redox biology, the Xian group has developed several novel fluorescent chemosensors for these two species. Recently, they prepared a fluorescent chemosensor 36, which enables dual-channel discrimination between H2S and H2Sn (Fig. 18).35 The design principle for this chemosensor is that H2S selectively reacts with the azidocoumarin moiety, while H2Sn only reacts with phenyl 2-(benzoylthio)benzoate, which results in the corresponding fluorescence “turn-on”. However, the real situation is more complicated since the azide group of 36 can be partially reduced by H2Sn and the reaction of H2S with azides results in the formation of H2Sn (Fig. 18). However, due to the FRET process, the reaction with H2Sn should just produce green fluorescence from rhodol. Furthermore, less than 0.5 equivalents of H2Sn are produced from the reaction of H2S (1 equivalent) and azide, therefore the reaction with H2S can produce emission signals from both coumarin (major) and rhodol (minor). Overall, 36 can detect H2S and H2Sn from distinct emission channels. This chemosensor has been used to image H2S and H2Sn in live cells. Moreover, this work provides a strategy for developing fluorescent chemosensors that can discriminate two or more closely related species using different fluorescence channels.
Hydrogen selenide (H2Se) can be thought of as analogous to H2S and it has been shown to be involved in many physiological and pathological processes. There are only a few fluorescent chemosensors for H2Se that have been reported to date. Recently, the Tang group reported a hemicyanine based NIR fluorescent chemosensor 37 for H2Se, using the selective cleavage of Se–N in benzoselenadizole by H2Se through nucleophilic displacement (Fig. 19).36 Initially, the free chemosensor is non-fluorescent due to the heavy atom effect of Se. However, after the addition of H2Se, the chemosensor undergoes a ca. 10-fold “turn-on” fluorescence response. Additionally, it was successfully used for imaging endogenous H2Se in live cells and in mice.
Chemical explosives such as 1,3,5-trinitroperhydro-1,3,5-triazine (RDX), picric acid (PA) and 2,4,6-trinitrotoluene (TNT) are a threat to public health and safety. Therefore, fluorescent chemosensors and sensor materials for the rapid and selective detection of chemical explosives at trace levels are of great importance. Anzenbacher Jr. and coworkers developed three pyrene based fluorescent chemosensors 39a, 39b and 39c for RDX (Fig. 21).38 These chemosensors show “turn on” fluorescence response to RDX based on different mechanisms. The fluorescence enhancement of 39a can be ascribed to protonation of the tertiary amines upon deprotonation from RDX. While, the formation of iminium cation and imine can be the reason for fluorescence enhancement of 39b and 39c, respectively. Furthermore, these three chemosensors were used to construct a fluorescent assay to discriminate different analytes.
Recently, the Gunnlaugsson group have reported a supramolecular Tröger's base derived zinc coordination polymer 40 for fluorescent sensing of phenolic–nitroaromatic explosives (Fig. 21).39 The aqueous suspension of 40 displayed strong green fluorescence at 520 nm, due to the ICT transition. A selective fluorescence quenching was observed towards phenolic–nitroaromatics (4-nitrophenol (4-NP), 2,4-dinitrophenol (2,4-DNP) and PA) in the presence of other competing nitroaromatic species. Furthermore, 40 displays reversible PA sensing and the detection limit towards PA was determined to be 26.3 ppb. All these results indicate that 40 is a proficient sensor material for rapid detection of phenolic–nitroaromatics. The authors have previously demonstrated the use of Tröger's base based naphthalimide structures as cellular imaging agents and as potential anticancer agents.
Sulfur mustard (SM), a chemical warfare agent, is known to be extremely toxic, quite stable, and easy to synthesize. Discovery of fluorescent chemosensors for the selective and sensitive detection of SM is of great importance. In 2013, the Anslyn group developed fluorescent turn-on chemosensor for a sulfur mustard simulant 2-chloroethyl ethyl sulfide (CEES) based on a metal-ion indicator displacement assay (IDA) (Fig. 22).40 In this system, they developed a supramolecular system containing two units including a receptor dithiol 41 and Cd2+–indicator complex 42. Dithiol 41 can rapidly react with CEES to yield a podand 43, which exhibits high affinity to Cd2+ and hence displaces an indicator (4-methylesculetin) from 42, leading to fluorescence enhancement at 460 nm. The detection limit of CEES was found to be 0.2 μM, and can detect nerve agent levels that pose a health risk.
Enantioselective fluorescent chemosensors is another hot topic in the field of chemosensors. It has gained tremendous interest in recent years. The Pu group have developed a series of enantioselective fluorescent chemosensors for the recognition of some important chiral compounds. In 2015, Pu, Yu and coworkers reported a 1,1′-bi-2-naphthol (BINOL)-based bis(naphthylimine) fluorescent chemosensor 44 for the detection of chiral functional amines (Fig. 23).41 In the presence of Zn(OAc)2, 44 can react with chiral amines to release 2-naphthylamine with a blue emission (λ1 = 427 nm), which allows the substrate concentration to be determined. The combination of the remaining chiral binaphthyl unit with the chiral substrates results in significant enantioselective fluorescence enhancements at λ2 > 500 nm, which facilitates the determination of enantiomeric composition. Thus, both concentration and enantiomeric composition can be determined by one measurement of the fluorescent response of 44. This design principle represents a potentially general strategy for the development of dual responsive fluorescent sensors.
Czarnik carried out pioneering work on anthrylpolyamines 45a–d to sense polyanions such as heparin, poly-L-glutamate, ds DNA (double-stranded DNA) and ss DNA (single-stranded DNA) in water (Fig. 24).42 These chemosensors display a red-shift and decrease in their emission spectra when bound to either ds DNA or to ss DNA. The chemosensor 45b is effective in binding to polyglutamate while 45c an excellent binder of heparin. They have been used to monitor the activity of pronase and heparinase, respectively.
Schmuck and co-workers reported a pyrene-based peptide beacon (fluorescent chemosensor 46) that was shown to intercalate with DNA (Fig. 25).43 In solution, the folded conformation of 46 exhibits a typical pyrene excimer emission. However, when bound to DNA the chemosensor undergoes a conformational change to the unfolded form. The change in conformation leads to a ratiometric change in fluorescence from excimer (490 nm) to monomer emission (406 nm).
Fig. 25 Structures of the fluorescent chemosensors 46 and the schematic illustration of 46 and Its Interaction with nucleic acid (the photographs show the corresponding cuvettes under UV light). Reproduced from ref. 43 with the permission of the American Chemical Society. |
For the purpose of protein labeling, Hamachi developed a fluorescent semi-synthetic chemosensor 47 based on the ligand-directed tosyl (LDT) chemistry (Fig. 26).44 In this quencher-tethered LDT (Q-LDT), the fluorophore (coumarin) is covalently attached to a protein ligand and an azoic fluorescence quencher via a labile sulfonate linkage. When the ligand binds to a target protein surface, the sulfonate undergoes nucleophilic cleavage, separating the coumarin fluorophore from the quencher. However, it still shows very weak fluorescence since the fluorophore and quencher remain close together within the ligand-binding site of the protein. However, addition of exogenous ligand leads to a fluorescence recovery as a result of the displacement of the quencher-tethered ligand (Fig. 26). This chemosensor has been applied for ligand binding assays of human carbonic anhydrase II (hCAII) and the SH2 domain in purified protein solutions as well as in crude cell lysates.
Fig. 26 Structures of the fluorescent chemosensors 47 and schematic illustration of the strategy for the Q-LDT-mediated construction of turn-on fluorescent biosensors. Reproduced from ref. 44 with the permission of the American Chemical Society. |
Recently, Kikuchi and coworkers developed a fluorescent chemosensor 48 for heterochromatin protein 1 using the photoactive yellow protein (PYP) as a tag (Fig. 27).45 The chemosensor consists of a hydroxy cinnamic as the PYP ligand, fluorescein the fluorophore, and nitrobenzene the quencher moiety. The acetylated fluorescein was used in 48 because esters are membrane permeable while digested fluorescein molecules are non-permeable. However, 48 can be rapidly digested by cellular esterases yielding the anionic-48 as shown in Fig. 27. Thus this chemosensor enables no-wash selective labeling of intracellular proteins fused to the PYP tag in a desirable time frame, without adhesion or accumulation of the tag or the probe with non-targeted organelles.
Fig. 27 Structures of the fluorescent chemosensors 48, anionic-48 and no-wash live cell imaging of protein labeling with 48 and maltose-binding protein (MBP) (top) and MBP-PYP (bottom) expressed in HEK 293T cells. Reproduced from ref. 45 with the permission of the Royal Society of Chemistry. |
Alzheimer's disease (AD) is a neurodegenerative disease that has a massive effect on an individual's memory, cognitive abilities and personality.46 Amyloid-β (Aβ) plaques are considered be a key pathological biomarker for AD. Therefore, the development of a chemosensor for the detection of Aβ plaques in vivo would be highly desirable for early diagnosis and monitoring of AD. Ahn and co-workers have developed a number of two-photon dyes 49a–e as candidates for fluorescent chemosensors for Aβ plaques (Fig. 28).46 The donor–acceptor dyes developed were shown to be environmentally sensitive due to the formation of intramolecular charge transfer (ICT) excited states. In hydrophobic environments such as organic solvents, the dyes exhibited strong fluorescence. However, in highly polar solvents the probes were only weakly fluorescent. Therefore, it was believed that these chemosensors could be used for the in vivo imaging of amyloid-β (Aβ) plaques due to the cross-β sheets of the amyloid plaques providing a hydrophobic environment inside and a hydrophilic environment outside. Among those NIR dyes, 49a was shown to be a novel fluorescent chemosensor for the detection of Aβ plaques. The chemosensor which possesses a considerable two-photon absorption cross-section value at 1000 nm was shown to have the ability to penetrate the blood brain barrier (BBB) and allow in vivo imaging of Aβ in a live mouse model.
Over 7 million people die annually as the result of cancer, with the number set to rise over the next 20 years. This highlights the need and importance of developing cancer biomarkers. A particularly useful candidate for cancer imaging is cyclooxygenase-2 (COX-2), given that different levels are expressed in tumors and in inflammatory lesions.47 Peng and coworkers reported a fluorescent chemosensor 50, which can distinguish healthy cells from cancerous cells and more importantly can distinguish cancerous cells from inflammatory cells (Fig. 29).47 In aqueous buffer, 50 is in a quenched folded-form, due to the PET process. An “off–on” fluorescence response was observed for inflammations and cancers where COX-2 is overexpressed. However the fluorescent emission is significantly different at the two sites due to different levels of COX-2 being expressed. For sites with inflammation, the fluorescence emission (615 nm) increases gradually over a COX-2 range of 0–0.12 μg mL−1. While for sites with cancer the fluorescence emission (615 nm) decreases and a new emission appears at 555 nm over a COX-2 range from 0.12–3.32 μg mL−1. Consequently, this chemosensor has been used to develop a fluorescence protocol for the selective discrimination of cancer over inflammation as shown in Fig. 29.
Fig. 29 Structures of the fluorescent chemosensors 50 and imaging tumors in vivo. (a) 50 (30 μM) was injected intravenously (30 μL). The incubation time was 30 min. (b) Visualization of tumor resection by the naked eye under ultraviolet illumination. Reproduced from ref. 47 with the permission of the American Chemical Society. |
In contrast to fluorescent chemosensor 50, which is based on conformational changes, there have been several reaction-based fluorescent chemosensors for cancer using other biomarkers. β-Galactosidase (β-gal) is an exoglycosidase that catalyses the hydrolysis of β-galactosides to generate monosaccharides through the cleavage of the glycosidic bond. β-Gal is widely recognized as a biomarker enzyme for cell senescence and primary ovarian cancer. Zhu and coworkers recently reported a ratiometric near-infrared (NIR) fluorescent chemosensor 51 for β-gal detection (Fig. 30).48 Upon hydrolysis, there was a visual colour change from a faint yellow to a rose red, which allows the systems to be used for colorimetric detection. A 14-fold fluorescence increase was observed in the ratio (I685nm/I500nm) or a 34-fold fluorescence increase was observed at 685 nm. This NIR emission provided the opportunity for the chemosensor to be used for in situ and in vivo visualization of β-gal activity in colorectal tumor mice models. The chemosensor was successfully applied for in vivo real-time capture of β-gal activity at a tumor site as visualized using high-resolution three-dimensional imaging.
Recently, the Ma group have reported a cresyl violet based fluorescent chemosensor 52 for the detection of leucine aminopeptidase (LAP). LAP is known to be widely distributed in organisms from bacteria to humans, including various cancer cells (Fig. 31).49 The chemosensor shows a colorimetric “off–on” fluorescence response to LAP and the detection limit was determined to be 0.42 ng mL−1. Thus it can be used to monitor the concentration changes of trace amounts of LAP in different biosamples. The results indicate that cancer cells with a higher level of LAP show much stronger resistance toward cisplatin. The authors demonstrated that LAP contributes to intrinsic resistance and serves as a simple monitor to reflect the relative resistance of cancer cells.
Alkaline phosphatase (ALP) belongs to a subfamily of phosphatases, which are found in mammalian tissues. ALP is known as a hydrolase enzyme, which is capable of catalyzing the hydrolysis of a phosphate ester from proteins, nucleic acids and other biological molecules. It has been suggested that elevated levels of ALP are linked to a number of diseases including cancer, cardiovascular, bone and hepatic diseases.50 Nagano et al. developed an “off–on” fluorescent chemosensor 53 for the analysis of western blots (Fig. 32).50 They achieved this through the attachment of a phosphate group to the phenolic group of 2-Me-4-OMe Tokyo green (TG), which became almost non-fluorescent. The hydrolysis of the phosphate ester by ALP resulted in a strong fluorescence enhancement and the chemosensor was shown to have a high affinity for western blots. Furthermore, this design strategy may deliver a general approach for the simple and rapid detection of proteins using western blots.
On reading this tutorial review, it may seem to young researchers that all the great problems in chemosensors research have already been solved. Nothing could be further from the truth, since we will always need “new” chemosensors for yet unknown analytes. This could be in the form of new biomarkers or trace pollutants in our air and water supplies. Also, biological and environmental analysis has increasingly stringent requirements imposed by regulatory bodies, so while a current chemosensor may work it may fall short of the required selectivity or sensitivity required for use in a specific practical application. So whether the problem requires bespoke new receptors or an improvement of existing systems, we will continue to need an increasing number of chemosensors to meet these challenges. In summary, we expect that chemosensor research will continue to expand and develop. As well as new and improved chemosensors, we anticipate that new applications or approaches to use existing fluorophores as chemosensors will emerge. For example, Gunnlaugsson and Scanlan have repurposed a naphthalimide fluorophore in the form of a “pre-probe”.55 These pre-probe chemosensors consist of a targeting group (carbohydrate) which is selectively cleaved (enzymatically) within target cancer cells to release the fluorophore allowing selective visualization. We envision that many of the other “old” chemosensors can similarly be repurposed for use in as yet unknown applications. In conclusion, the past set us going in the right direction, the present provided us with the challenges that need to be solved and the future gives us great hope that our lives will be improved by chemosensors.
Albert Einstein: “Learn from yesterday, live for today, hope for tomorrow.”
This journal is © The Royal Society of Chemistry 2017 |